Bg pattern

FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information Leaflet

Flebostasin Retard 50 mg prolonged-release hard capsules

Escin

Read the entire leaflet carefully before starting to take this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet:

  1. What is Flebostasin Retard and what is it used for
  2. What you need to know before taking Flebostasin Retard
  3. How to take Flebostasin Retard
  4. Possible side effects
  5. Storage of Flebostasin Retard
  6. Package contents and additional information

1. What is Flebostasin Retard and what is it used for

Flebostasin Retard is a medicine that belongs to the group of capillary protectors.

Flebostasin Retard is indicated for the short-term relief (for two to three months) of edema and symptoms related to chronic venous insufficiency.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Flebostasin Retard

Do not take Flebostasin Retard

If you are allergic to the active substance or to any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to take Flebostasin Retard.

If you have any disease, you should inform your doctor.

Children and adolescents

It should not be administered to children.

Taking Flebostasin Retard with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medicine.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Since there is no adequate experience regarding the safety of Flebostasin Retard during pregnancy and breastfeeding, its use should be avoided in these situations.

Driving and using machines:

No effects have been described that affect the ability to drive and use machines.

3. How to take Flebostasin Retard

Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Your doctor will indicate the duration of your treatment with Flebostasin Retard.

The recommended dose is 1 capsule in the morning and 1 capsule in the evening. Take the capsules whole, without chewing, with a little liquid, and preferably before meals.

If you think the effect of Flebostasin Retard is too strong or too weak, inform your doctor or pharmacist.

If you take more Flebostasin Retard than you should

If you take more capsules than you should or if a child accidentally ingests one or more capsules, contact your doctor or go to the nearest hospital emergency department immediately and take the medicine packaging with you.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Phone 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Flebostasin Retard

If you forget to take a dose, take the usual dose the next day. Do not take a double dose to make up for the missed doses.

If you stop taking Flebostasin Retard

Do not stop treatment without consulting your doctor, as there is a possibility that the treatment may lose its effect.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

During treatment, you may experience stomach heaviness or mild abdominal discomfort. Skin alterations such as itching, redness, and rash may also occur, although rarely.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Flebostasin Retard

Keep out of sight and reach of children.

Store below 25°C.

Keep in the original packaging to protect from moisture.

Do not use this medicine after the expiration date stated on the packaging after the abbreviation "CAD". The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Package contents and additional information

Composition of Flebostasin Retard

The active substance is escin. Each Flebostasin Retard capsule contains 50 mg of escin (corresponding to 300 mg of aesculus hippocastanum extract).

  • The other components are vinylpyrrolidone-vinyl acetate copolymer, talc, dextrin, ammonio methacrylate copolymer (Type B), ammonio methacrylate copolymer (Type A), and triethyl citrate.
  • Capsule components:

Gelatin, sodium lauryl sulfate, black iron oxide (E-172), red iron oxide (E-172), yellow iron oxide (E-172), titanium dioxide (E-171), indigo carmine (E-132), and quinoline yellow (E-104).

Appearance and packaging of the product

Flebostasin Retard is presented in the form of prolonged-release hard capsules. The cap of the capsule is opaque brown and the body is transparent green.

Each package contains 60 prolonged-release hard capsules.

Marketing authorization holder:

Glenwood GmbH

Pharmazeutische Erzeugnisse

Arabellastr.17

81925 Munich

Germany

Manufacturer:

SWISS CAPS GmbH

Grassingerstrasse 9

83043 Bad Aibling

Germany

Or

FARMASIERRA, S.A.

Carretera. Irún, Km. 26,200

28700 San Sebastián de los Reyes (Madrid)

Date of the last revision of this leaflet: September 2019.

Other sources of information

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES

Discuss questions about FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (771)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES?
FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES?
FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES is manufactured by Glenwood Gmbh Pharmazeutische Erzeugnisse. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to FLEBOSTASIN RETARD 50 mg PROLONGED-RELEASE HARD CAPSULES?
Other medicines with the same active substance () include DAFLON 500 MG FILM-COATED TABLETS, DIOFLAV 500 MG FILM-COATED TABLETS, DIOSMIN KERN PHARMA 500 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media